Infections in Patients Receiving Subcutaneous Biological Treatments for Moderate to Severe Psoriasis

類似資料

• Subcutaneous Biological Treatments for Moderate to Severe Psoriasis: Interpreting Safety Data by Network Meta-Analysis
  著者:: Messori, Andrea, 等
  出版事項: (2015)
• The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments
  著者:: Gisondi, Paolo, 等
  出版事項: (2020)
• The limitations of observational studies on the treatment of severe sepsis – authors' response
  著者:: Messori, Andrea, 等
  出版事項: (2002)
• Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis
  著者:: Zhang, Mingliang, 等
  出版事項: (2015)
• Evaluating Potential Disease‐Mediated Protein‐Drug Interactions in Patients With Moderate‐to‐Severe Plaque Psoriasis Receiving Subcutaneous Guselkumab
  著者:: Zhu, Yaowei, 等
  出版事項: (2020)